Patent · US Active

Isolation of skeletal precursor cells

US7863045B2 · kind B2 · utility

0Cited by

13References

8Claims

0Family size

Assignee

TIGENIX NV · BE

Inventors

Frank Luyten · Rockville, US
Cosimo De Bari · Leuven, BE
Francesco Dell'Accio · London, GB

Key dates

Filing date	Jul 18, 2008
Grant date	Jan 4, 2011
Priority date	—
Expiry date	Dec 28, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2502/1317
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Cartilage-derived morphogenetic protein CDMP-1 or a transforming growth factor β having at least 80% homology with CDMP-1, or a factor co-expressed and/or co-detectable therewith, is used as a marker of skeletal precursor cells from any part of a mammalian body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.